Introduction: The Secret Language of Cells

Imagine living in a crowded city where every person, shop, and office needs to constantly exchange messages. Some people shout across the street, others send emails, but a select few slip sealed envelopes directly into the hands of their recipients. In the world of biology, those sealed envelopes are extracellular vesicles (EVs)—tiny packages that cells release to deliver information.

Not very long ago, EVs were  dismissed as “cellular garbage bags,” thought to contain nothing but waste. But modern research has revealed that they are, in fact, sophisticated messengers carrying DNA, RNA, proteins, lipids, and other molecular cargo. These particles allow cells to talk to each other—and even across species boundaries, between humans and the microbes living inside us.

This hidden system of communication has profound effects throughout the body, not only for localized communication, but  systemically between organs, and between the human microbiome and host. . EVs are involved in regulating the microbiome, but they can also spread disease signals, fuel cancer, and even shape how our immune system evolved. Scientists are now exploring how EVs could be harnessed to improve the immune system, especially in the fight against cancer.

Let’s take a closer look into the fascinating world of EVs.

What Exactly Are Extracellular Vesicles?

Think of EVs as tiny soap bubbles released by cells. They’re wrapped in a lipid (fatty) membrane that protects their contents and helps them fuse with target cells. There are different types, but the two main ones are:

• Exosomes: Very small (30–150 nanometers), formed inside the cell and released when storage compartments fuse with the outer membrane.
• Microvesicles: Larger (100–1000 nanometers), pinched directly from the cell’s surface.
• Outer membrane vesicles (OMVs): Special to bacteria, especially Gram-negative ones, often carrying toxins, enzymes, or genetic material.

For comparison, a nanometer is one-billionth of a meter. That means thousands of EVs could fit across the width of a human hair. Despite their small size, their impact is enormous.

The Human–Microbe Dialogue: EVs as Translators

Our bodies are home to trillions of microbes—bacteria, viruses, fungi—collectively known as the microbiome. Most of them aren’t harmful; many are essential for digestion, immunity, and metabolism. But how do we coexist peacefully with so many foreign organisms? EVs are a big part of the answer.

Microbial EVs → Host

• Friendly gut bacteria, like Bacteroides fragilis, release EVs carrying polysaccharide A. This molecule helps train our immune system to tolerate “friendly” microbes by encouraging the growth of regulatory T cells—immune cells that calm inflammation.
• On the flip side, harmful bacteria release OMVs packed with lipopolysaccharides (LPS) or toxins that stimulate strong immune reactions. If uncontrolled, this can lead to chronic inflammation.

Host EVs → Microbes

• Our intestinal cells release EVs into the gut lumen. Some carry antimicrobial peptides (small molecules that kill bacteria). Others deliver microRNAs, which can actually influence bacterial gene expression, fine-tuning the microbiome.
• Immune cells also release EVs that carry signals of tolerance, teaching the microbiome which species are “safe” to keep around.

In this way, EVs act like diplomatic couriers, delivering peace treaties—or sometimes declarations of war—between us and our microbes.

EVs and Disease: When Communication Goes Wrong

(Iyaswamy, et al). 

Like any communication system, the EV network can be hijacked or disrupted. This contributes to a range of diseases:

1. Inflammatory Disorders (IBD, Crohn’s disease, ulcerative colitis):
   Microbial EVs overloaded with LPS overstimulate receptors in the gut, causing constant inflammation.

2. Metabolic Disease (Diabetes, Obesity):
   Some microbial EVs sneak into the bloodstream and interfere with insulin signaling, contributing to metabolic imbalance.

3. Cancer:

   • Tumor-derived EVs carry signals that suppress the immune system, helping the cancer evade detection.
   • Microbiome-derived EVs can influence the tumor microenvironment, sometimes by carrying DNA-damaging substances.

4. Neurological Disorders:
   EVs play a role in the gut–brain axis. Microbial EVs can carry neurotransmitter precursors or inflammatory molecules that affect brain health, contributing to conditions like Parkinson’s or depression.

In short, EVs can either maintain balance or tip the scales toward disease.

Evolutionary Insights: EVs as Immune Teachers

One of the most fascinating aspects of EV biology is how it may have shaped the evolution of the human immune system.

• Tolerance: Constant exposure to microbial EVs likely taught our immune system to tolerate harmless microbes while staying alert to pathogens. Without this training, autoimmunity would be rampant.
• Diversity: Some evidence suggests microbial EVs can enable horizontal gene transfer—swapping bits of genetic information across species. Over evolutionary time, this may have influenced the diversity of immune receptors.
• Co-adaptation: By allowing complex molecular exchanges, EVs helped humans and microbes form stable partnerships, which improved survival against external threats.

So, in a way, EVs were evolutionary “professors,” teaching our immune system how to balance vigilance with tolerance.

EVs, Cancer, and the Immune System: A New Frontier

Cancer is a master of deception. Tumors release EVs that:

• Suppress immune cells (like T cells and natural killer cells).
• Reprogram nearby cells to support tumor growth.
• Prepare distant sites in the body (“pre-metastatic niches”) for cancer spread.

But here’s the exciting part: scientists are learning how to hijack EVs back—turning them into allies in cancer treatment.

Potential Strategies

1. EV-based Biomarkers: Detecting tumor-derived EVs in blood could allow earlier cancer diagnosis.
2. EV-based Vaccines: Engineering EVs to carry tumor antigens can “teach” the immune system to recognize and attack cancer cells.
3. EV-mediated Drug Delivery: Since EVs naturally fuse with cells, they can be used to deliver chemotherapy or immunotherapy directly into tumors, reducing side effects.
4. Microbiome-targeted EVs: Adjusting microbial EV signaling in the gut may indirectly boost the immune system’s ability to fight tumors.

This field is still young, but it’s growing fast.

Supporting the Immune System in the Age of EVs

You might be wondering: What does all this mean for me right now? While clinical applications are still in development, here are some evidence-based strategies and resources related to EVs and immunity:

1. Nutrition and Microbiome Health

   • A balanced diet rich in fiber supports gut microbes that release beneficial EVs.
   • Fermented foods (yogurt, kimchi, sauerkraut) promote microbial diversity, which strengthens immune balance.

2. Exercise

   • Physical activity stimulates the release of EVs from muscle and immune cells. These EVs carry anti-inflammatory molecules that improve immune resilience.

3. Clinical Trials and Research

   • Many ongoing trials are testing EV-based cancer vaccines and liquid biopsy tests. Following updates on ClinicalTrials.gov can help you stay informed.

4. Resources for Deeper Learning

   • International Society for Extracellular Vesicles (ISEV): https://www.isev.org – leading organization in EV research.
   • National Cancer Institute (NCI): Cancer and the Microbiome – overview of how microbes and their products influence cancer.
   • Review Article: Raposo G. & Stoorvogel W. (2013). Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol.

Conclusion: The Future of Tiny Messengers

Extracellular vesicles are rewriting what we know about biology. Once dismissed as cellular trash, they are now recognized as central players in communication, disease, and evolution. They mediate peace treaties between humans and their microbes, but they can also act as saboteurs in cancer and chronic disease.

The most exciting frontier lies in medicine: EVs may become the next generation of cancer diagnostics, vaccines, and drug delivery systems. By learning how to harness these natural couriers, we may one day improve immune function, detect cancer earlier, and design therapies with pinpoint precision.

In short, EVs show us that the smallest messengers can have the loudest voices in shaping our health—and possibly our future.

Sources

Iyaswamy, A., Lu, K., Guan, X.-J., Kan, Y., Su, C., Liu, J., Jaganathan, R., Vasudevan, K., Paul, J., Thakur, A., & Li, M. (2023). Impact and Advances in the Role of Bacterial Extracellular Vesicles in Neurodegenerative Disease and Its Therapeutics. Biomedicines, 11(7), 2056. https://doi.org/10.3390/biomedicines11072056

Colombo M. et al. (2014). Extracellular vesicles: composition, biogenesis and function. Nat Rev Mol Cell Biol.

Raposo G., Stoorvogel W. (2013). Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol.

Kuehn M.J., Kesty N.C. (2005). Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev.

Shen Y. et al. (2012). Bacteroides fragilis polysaccharide A induces regulatory T cells. Science.

Kaparakis-Liaskos M., Ferrero R.L. (2015). Immune modulation by bacterial outer membrane vesicles. Nat Rev Immunol.

Liu S. et al. (2016). Host epithelial exosomes regulate gut microbiota composition. Cell Host Microbe.

Cheng Y. et al. (2019). Extracellular vesicles in inflammatory bowel disease. J Crohns Colitis.

Ashrafian F. et al. (2019). The role of gut microbial extracellular vesicles in metabolic disease. Cell Mol Life Sci.

Greening D.W., Simpson R.J. (2018). Extracellular vesicles in cancer: mechanisms and biomarkers. Nat Rev Cancer.

Park J. et al. (2017). Gut-microbiota-derived extracellular vesicles contribute to Parkinson’s disease pathology. Cell Host Microbe.

Belkaid Y., Hand T.W. (2014). Role of the microbiota in immunity and inflammation. Cell.

Toyofuku M. et al. (2019). Prokaryotic membrane vesicles: new insights. Nat Rev Microbiol.